AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2014
Jan 3, 2014
30016_dirs_2014-01-03_5c204d01-6f46-4983-8e86-711772cfe112.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2014-01-01
Reporting Person: MCKEON BRIAN P (Executive VP, CFO & Treasurer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-01-01 | Non-Qualified Stock Option (right to buy) | $106.3700 | A | 18918 | Acquired | 2023-12-31 | Common Stock (18918) | Direct |
| 2014-01-01 | Incentive Stock Option (right to buy) | $106.3700 | A | 4700 | Acquired | 2023-12-31 | Common Stock (4700) | Direct |
| 2014-01-01 | Restricted Stock Unit | $ | A | 7051 | Acquired | Common Stock (7051) | Direct |
Footnotes
F1: Grant of options to buy shares of common stock that vest in five equal annual installments, beginning on the first anniversary date (01/01/2015) of the date of grant.
F2: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (01/01/2015) of the date of grant.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Mar 13